| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3 December 2002 | Volume 137 Issue 11 | Pages 904-914
Background: Mounting evidence indicates that subclinical thyroid dysfunction has important clinical effects and prognostic implications, supporting the view that it is not a compensated biochemical change sensu strictu.
Purpose: To review clinical information on the effects of subclinical thyroid dysfunction on the heart.
Data Sources: English-language articles identified from files and a MEDLINE search (1970September 2001), references of relevant articles, textbooks, and meeting abstracts.
Study Selection: Reports on the effects of subclinical hypothyroidism and subclinical hyperthyroidism on the cardiovascular system in humans.
Data Extraction: Data on cardiac structure and performance, arrhythmias, and risk for coronary artery disease were independently assessed by all authors and summarized.
Data Synthesis: Subclinical hypothyroidism is associated with impaired left ventricular diastolic function at rest, systolic dysfunction on effort, and enhanced risk for atherosclerosis and myocardial infarction. Subclinical hyperthyroidism is associated with increased heart rate, atrial arrhythmias, increased left ventricular mass with marginal concentric remodeling, impaired ventricular relaxation, reduced exercise performance, and increased risk for cardiovascular death. All abnormalities were reversed by restoration of euthyroidism (subclinical hypothyroidism) or were blunted by ß-blockade and tailoring of the L-thyroxine dose (subclinical hyperthyroidism).
Conclusion: The heart responds to the minimal but persistent changes in circulating thyroid hormone levels typical of subclinical thyroid dysfunction. Thus, the condition is not a compensated biochemical change sensu strictu, and timely treatment should be considered in an attempt to avoid adverse cardiovascular effects.
Author and Article Information
From the University of Naples Federico II School of Medicine, Naples, Italy.
Acknowledgments: The authors thank Jean Ann Gilder for editing the text.
Grant Support: In part by Grant of Ministero d'niversità e della Ricerca Scientifica e Tecnologica (co-financed project, year 2000) (no. MM6263471-005).
Requests for Single Reprints: Bernadette Biondi, MD, Department of Clinical and Molecular Endocrinology and Oncology, University of Naples Federico II School of Medicine, via S. Pansini 5, 80131 Naples, Italy; e-mail, bebiondi{at}libero.it.
Current Author Addresses: Drs. Biondi and Lombardi: Department of Clinical and Molecular Endocrinology and Oncology, University of Naples Federico II School of Medicine, 80131 Naples, Italy.
Drs. Palmieri and Fazio: Department of Clinical Medicine and Cardiovascular Sciences, University of Naples Federico II School of Medicine, 80131 Naples, Italy. REVIEW
Effects of Subclinical Thyroid Dysfunction on the Heart
![]()
Related articles in Annals:
This article has been cited by other articles:
![]() |
A. L. D. Riis, J. O. L. Jorgensen, P. Ivarsen, J. Frystyk, J. Weeke, and N. Moller Increased Protein Turnover and Proteolysis Is an Early and Primary Feature of Short-Term Experimental Hyperthyroidism in Healthy Women J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 3999 - 4005. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Rodondi, D. C. Bauer, A. R. Cappola, J. Cornuz, J. Robbins, L. P. Fried, P. W. Ladenson, E. Vittinghoff, J. S. Gottdiener, and A. B. Newman Subclinical Thyroid Dysfunction, Cardiac Function, and the Risk of Heart Failure: The Cardiovascular Health Study J. Am. Coll. Cardiol., September 30, 2008; 52(14): 1152 - 1159. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Haentjens, A. Van Meerhaeghe, K. Poppe, and B. Velkeniers Subclinical thyroid dysfunction and mortality: an estimate of relative and absolute excess all-cause mortality based on time-to-event data from cohort studies Eur. J. Endocrinol., September 1, 2008; 159(3): 329 - 341. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Biondi Should we treat all subjects with subclinical thyroid disease the same way? Eur. J. Endocrinol., September 1, 2008; 159(3): 343 - 345. [Full Text] [PDF] |
||||
![]() |
M. Dorr, K. Empen, D. M Robinson, H. Wallaschofski, S. B Felix, and H. Volzke The association of thyroid function with carotid artery plaque burden and strokes in a population-based sample from a previously iodine-deficient area Eur. J. Endocrinol., August 1, 2008; 159(2): 145 - 152. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. F. A. Eustatia-Rutten, E. P. M. Corssmit, K. A. Heemstra, J. W. A. Smit, R. C. Schoemaker, J. A. Romijn, and J. Burggraaf Autonomic Nervous System Function in Chronic Exogenous Subclinical Thyrotoxicosis and the Effect of Restoring Euthyroidism J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2835 - 2841. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Salerno, U. Oliviero, T. Lettiero, V. Guardasole, D. M. Mattiacci, L. Saldamarco, D. Capalbo, A. Lucariello, L. Sacca, and A. Cittadini Long-Term Cardiovascular Effects of Levothyroxine Therapy in Young Adults with Congenital Hypothyroidism J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2486 - 2491. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. N. Pearce, P. W. F. Wilson, Q. Yang, R. S. Vasan, and L. E. Braverman Thyroid Function and Lipid Subparticle Sizes in Patients with Short-Term Hypothyroidism and a Population-Based Cohort J. Clin. Endocrinol. Metab., March 1, 2008; 93(3): 888 - 894. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Biondi and D. S. Cooper The Clinical Significance of Subclinical Thyroid Dysfunction Endocr. Rev., February 1, 2008; 29(1): 76 - 131. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. S. Mittra, R. D. Niederkohr, C. Rodriguez, T. El-Maghraby, and I. R. McDougall Uncommon Causes of Thyrotoxicosis J. Nucl. Med., February 1, 2008; 49(2): 265 - 278. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. A. Martins, F. C. Doin, W. R. Komatsu, T. L. Barros-Neto, V. A. Moises, and J. Abucham Growth Hormone Replacement Improves Thyroxine Biological Effects: Implications for Management of Central Hypothyroidism J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4144 - 4153. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Iervasi, S. Molinaro, P. Landi, M. C. Taddei, E. Galli, F. Mariani, A. L'Abbate, and A. Pingitore Association Between Increased Mortality and Mild Thyroid Dysfunction in Cardiac Patients Arch Intern Med, July 23, 2007; 167(14): 1526 - 1532. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H Duntas and B. Biondi Short-term hypothyroidism after Levothyroxine-withdrawal in patients with differentiated thyroid cancer: clinical and quality of life consequences Eur. J. Endocrinol., January 1, 2007; 156(1): 13 - 19. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-L. Fabrizio, D. B. Vitantonio, T. Enrica, D. C. Andrea, M. Fabio, A. Lucia, P. Caterina, C. Nadia, D. D. M. Grazia, N. Carmela, et al. Early textural and functional alterations of left ventricular myocardium in mild hypothyroidism. Eur. J. Endocrinol., July 1, 2006; 155(1): 3 - 9. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. D. Owen, C. Rajiv, D. Vinereanu, T. Mathew, A. G. Fraser, and J. H. Lazarus Subclinical Hypothyroidism, Arterial Stiffness, and Myocardial Reserve J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2126 - 2132. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Annerbo, L.-O. Wahlund, and J. Lokk The Significance of Thyroid-Stimulating Hormone and Homocysteine in the Development of Alzheimer's Disease in Mild Cognitive Impairment: A 6-Year Follow-up Study American Journal of Alzheimer's Disease and Other Dementias, May 1, 2006; 21(3): 182 - 188. [Abstract] [PDF] |
||||
![]() |
M. Dorr, D. M. Robinson, H. Wallaschofski, C. Schwahn, U. John, S. B. Felix, and H. Volzke Low Serum Thyrotropin Is Associated with High Plasma Fibrinogen J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 530 - 534. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Rodondi, A. B. Newman, E. Vittinghoff, N. de Rekeneire, S. Satterfield, T. B. Harris, and D. C. Bauer Subclinical Hypothyroidism and the Risk of Heart Failure, Other Cardiovascular Events, and Death Arch Intern Med, November 28, 2005; 165(21): 2460 - 2466. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Walsh, A. P. Bremner, M. K. Bulsara, P. O'Leary, P. J. Leedman, P. Feddema, and V. Michelangeli Subclinical Thyroid Dysfunction as a Risk Factor for Cardiovascular Disease Arch Intern Med, November 28, 2005; 165(21): 2467 - 2472. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-D. Tang, J. A. Kuzman, S. Said, B. E. Anderson, X. Wang, and A. M. Gerdes Low Thyroid Function Leads to Cardiac Atrophy With Chamber Dilatation, Impaired Myocardial Blood Flow, Loss of Arterioles, and Severe Systolic Dysfunction Circulation, November 15, 2005; 112(20): 3122 - 3130. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. D. Riis, T. K. Hansen, S. Thiel, C. H. Gravholt, S. Gjedde, L. C. Gormsen, J. O. L. Jorgensen, J. Weeke, and N. Moller Thyroid hormone increases mannan-binding lectin levels Eur. J. Endocrinol., November 1, 2005; 153(5): 643 - 649. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. A. Smit, C. F. A. Eustatia-Rutten, E. P. M. Corssmit, A. M. Pereira, M. Frolich, G. B. Bleeker, E. R. Holman, E. E. van der Wall, J. A. Romijn, and J. J. Bax Reversible Diastolic Dysfunction after Long-Term Exogenous Subclinical Hyperthyroidism: A Randomized, Placebo-Controlled Study J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6041 - 6047. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Caraccio, A. Natali, A. Sironi, S. Baldi, S. Frascerra, A. Dardano, F. Monzani, and E. Ferrannini Muscle Metabolism and Exercise Tolerance in Subclinical Hypothyroidism: A Controlled Trial of Levothyroxine J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4057 - 4062. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Casu, C. Cappi, V. Patrone, E. Repetto, M. Giusti, F. Minuto, and G. Murialdo Sympatho-vagal control of heart rate variability in patients treated with suppressive doses of L-thyroxine for thyroid cancer Eur. J. Endocrinol., June 1, 2005; 152(6): 819 - 824. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zoncu, F. Pigliaru, C. Putzu, L. Pisano, S. Vargiu, M. Deidda, S. Mariotti, and G. Mercuro Cardiac function in borderline hypothyroidism: a study by pulsed wave tissue Doppler imaging Eur. J. Endocrinol., April 1, 2005; 152(4): 527 - 533. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ripoli, A. Pingitore, B. Favilli, A. Bottoni, S. Turchi, N. F. Osman, D. De Marchi, M. Lombardi, A. L'Abbate, and G. Iervasi Does subclinical hypothyroidism affect cardiac pump performance?: Evidence from a magnetic resonance imaging study J. Am. Coll. Cardiol., February 1, 2005; 45(3): 439 - 445. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dorr, B. Wolff, D. M. Robinson, U. John, J. Ludemann, W. Meng, S. B. Felix, and H. Volzke The Association of Thyroid Function with Cardiac Mass and Left Ventricular Hypertrophy J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 673 - 677. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Biondi, E. A. Palmieri, M. Klain, M. Schlumberger, S. Filetti, and G. Lombardi Subclinical hyperthyroidism: clinical features and treatment options Eur. J. Endocrinol., January 1, 2005; 152(1): 1 - 9. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C. Ho, A. D. Chapital, and M. Yu Hypothyroidism and Adrenal Insufficiency in Sepsis and Hemorrhagic Shock Arch Surg, November 1, 2004; 139(11): 1199 - 1203. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. B. Samollow, G. Perez, C. M. Kammerer, D. Finegold, P. W. Zwartjes, L. M. Havill, A. G. Comuzzie, M. C. Mahaney, H. H. Goring, J. Blangero, et al. Genetic and Environmental Influences on Thyroid Hormone Variation in Mexican Americans J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3276 - 3284. [Abstract] [Full Text] [PDF] |
||||
![]() |
E H Hoogendoorn, M den Heijer, A P J van Dijk, and A R Hermus Subclinical hyperthyroidism: to treat or not to treat? Postgrad. Med. J., July 1, 2004; 80(945): 394 - 398. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A.D.M. van Osch, E. Hogervorst, M. Combrinck, and A. D. Smith Low thyroid-stimulating hormone as an independent risk factor for Alzheimer disease Neurology, June 8, 2004; 62(11): 1967 - 1971. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Biondi, G. Lombardi, and E. A. Palmieri Screening and Treatment for Subclinical Thyroid Disease JAMA, April 7, 2004; 291(13): 1562 - 1562. [Full Text] [PDF] |
||||
![]() |
M. Helfand Screening for Subclinical Thyroid Dysfunction in Nonpregnant Adults: A Summary of the Evidence for the U.S. Preventive Services Task Force Ann Intern Med, January 20, 2004; 140(2): 128 - 141. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. Surks, E. Ortiz, G. H. Daniels, C. T. Sawin, N. F. Col, R. H. Cobin, J. A. Franklyn, J. M. Hershman, K. D. Burman, M. A. Denke, et al. Subclinical Thyroid Disease: Scientific Review and Guidelines for Diagnosis and Management JAMA, January 14, 2004; 291(2): 228 - 238. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. F. Col, M. I. Surks, and G. H. Daniels Subclinical Thyroid Disease: Clinical Applications JAMA, January 14, 2004; 291(2): 239 - 243. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fazio, E. A. Palmieri, G. Lombardi, and B. Biondi Effects of Thyroid Hormone on the Cardiovascular System Recent Prog. Horm. Res., January 1, 2004; 59(1): 31 - 50. [Abstract] [Full Text] |
||||
![]() |
J. Auer, R. Berent, and B. Eber Subclinical Thyroid Dysfunction and the Heart Ann Intern Med, November 18, 2003; 139(10): 865 - 866. [Full Text] [PDF] |
||||
![]() |
A. M. Sawka and V. Fatourechi Subclinical Thyroid Dysfunction and the Heart Ann Intern Med, November 18, 2003; 139(10): 866 - 866. [Full Text] [PDF] |
||||
![]() |
E. S. Ganotakis, K. Mandalaki, M. Tampakaki, N. Malliaraki, E. Mandalakis, G. Vrentzos, J. Melissas, and E. Castanas Subclinical Hypothyroidism and Lipid Abnormalities in Older Women Attending a Vascular Disease Prevention Clinic: Effect of Thyroid Replacement Therapy Angiology, September 1, 2003; 54(5): 569 - 576. [Abstract] [PDF] |
||||